Mutational Status of KRAS, BRAF, NRAS and PIK3CA in Primary Clear Cell Ovarian Carcinoma

被引：0
|
作者：
Zannoni, Gian Franco
Chiarello, Gaia
Petrillo, Marco
Improta, Giuseppina
Rossi, Esther D.
Fadda, Guido
Fraggetta, Filippo
机构：
[1] Univ Cattolica Sacro Cuore, I-00168 Rome, Italy
[2] IRCCS CROB Hosp, Potenza, Italy
[3] Org Osped Cannizzaro, Catania, Italy
来源：
MODERN PATHOLOGY | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1267
引用
收藏
页码：316A / 317A
页数：2
相关论文
共 50 条
  • [21] KRAS, BRAF, PIK3CA, and human papilloma virus (HPV) status in squamous cell anal carcinoma (SCAC).
    Gardini, Andrea Casadei
    Capelli, Laura
    Ulivi, Paola
    Giannini, Massimo
    Freier, Eva
    Tamberi, Stefano
    Passardi, Alessandro
    Rosetti, Paola
    Calistri, Daniele
    Saragoni, Luca
    Puccetti, Maurizio
    Valgiusti, Martina
    Amadori, Dino
    Frassineti, Giovanni Luca
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [22] Scanning for KRAS, NRAS, BRAF, and PIK3CA Mutations by DNA Melting Analysis with TaqMan Probes
    Botezatu, I. V.
    Panchuk, I. O.
    Stroganova, A. M.
    Senderovich, A. I.
    Kondratova, V. N.
    Shelepov, V. P.
    Lichtenstein, A. V.
    MOLECULAR BIOLOGY, 2017, 51 (01) : 41 - 48
  • [23] Scanning for KRAS, NRAS, BRAF, and PIK3CA mutations by DNA melting analysis with TaqMan probes
    I. V. Botezatu
    I. O. Panchuk
    A. M. Stroganova
    A. I. Senderovich
    V. N. Kondratova
    V. P. Shelepov
    A. V. Lichtenstein
    Molecular Biology, 2017, 51 : 41 - 48
  • [24] Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study
    Grazia Palomba
    Valentina Doneddu
    Antonio Cossu
    Panagiotis Paliogiannis
    Antonella Manca
    Milena Casula
    Maria Colombino
    Annamaria Lanzillo
    Efisio Defraia
    Antonio Pazzola
    Giovanni Sanna
    Carlo Putzu
    Salvatore Ortu
    Mario Scartozzi
    Maria Teresa Ionta
    Giovanni Baldino
    Giuseppina Sarobba
    Francesca Capelli
    Tito Sedda
    Luciano Virdis
    Michela Barca
    Giulia Gramignano
    Mario Budroni
    Francesco Tanda
    Giuseppe Palmieri
    Journal of Translational Medicine, 14
  • [25] Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study
    Palomba, Grazia
    Doneddu, Valentina
    Cossu, Antonio
    Paliogiannis, Panagiotis
    Manca, Antonella
    Casula, Milena
    Colombino, Maria
    Lanzillo, Annamaria
    Defraia, Efisio
    Pazzola, Antonio
    Sanna, Giovanni
    Putzu, Carlo
    Ortu, Salvatore
    Scartozzi, Mario
    Ionta, Maria Teresa
    Baldino, Giovanni
    Sarobba, Giuseppina
    Capelli, Francesca
    Sedda, Tito
    Virdis, Luciano
    Barca, Michela
    Gramignano, Giulia
    Budroni, Mario
    Tanda, Francesco
    Palmieri, Giuseppe
    JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
  • [26] Relationship of PIK3CA mutation between ovarian clear cell carcinoma and endometrium
    Murakami, Kosuke
    Takaya, Hisamitsu
    Nakai, Hidekatsu
    Matsumura, Noriomi
    CANCER SCIENCE, 2021, 112 : 771 - 771
  • [27] Clinicopathologic and biological analysis of PIK3CA mutation in ovarian clear cell carcinoma
    Rahman, Munmun
    Nakayama, Kentaro
    Rahman, Mohammed Tanjimur
    Nakayama, Naomi
    Ishikawa, Masako
    Katagiri, Atsuko
    Iida, Kouji
    Nakayama, Satoru
    Otsuki, Yoshiro
    Shih, Ie-Ming
    Miyazaki, Kohji
    HUMAN PATHOLOGY, 2012, 43 (12) : 2197 - 2206
  • [28] Factors associated with disconcordance of KRAS, NRAS, BRAF, PIK3CA mutation status in the primary tumor and metastases in patients (pts) with colorectal cancer (CRC)
    Fedyanin, M.
    Stroganova, A.
    Senderovich, A.
    Dranko, S.
    Tryakin, A.
    Polyanskaya, E.
    Popova, A.
    Sekhina, O.
    Rasulov, A.
    Gordeev, S.
    Sagaydak, I.
    Tjulandin, S.
    ANNALS OF ONCOLOGY, 2016, 27
  • [29] Concordance of KRAS, NRAS, BRAF, PIK3CA mutation status in the primary tumor (PT) and metachronous metastases in patients (pts) with colorectal cancer (CRC)
    Fedyanin, Mikhail
    Stroganova, Anna
    Senderovich, Anastasia
    Dranko, Svetlana
    Tryakin, Alexey
    Pokataev, Ilya
    Polyanskaya, Elizaveta
    Gordeev, Sergey
    Rasulov, Arsen
    Polyakov, Alex
    Sagaydak, Igor
    Tjulandin, Sergei
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [30] BRAF and NRAS mutational status in clear cell sarcoma.
    Robert, C
    Berissi, S
    Kannengiesser, C
    Coindre, JM
    Bui, B
    Peyrot, P
    Lacroix, L
    Terrier, P
    Le Cesne, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 816S - 816S
12345